Corporate Overview
Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. In addition to REMOXY, a unique, abuse-resistant controlled-release oxycodone, the Company has three drug candidates in clinical programs, including a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well as PTI-202 and PTI-721. Pain Therapeutics is also working on a new treatment for patients with hemophilia.
Pain Therapeutics Stock Information
| Current Price: |
$5.41 |
| Change |
- 2.17%
0.12 |
| Day High |
$5.47 |
| Day Low |
$5.28 |
| Volume |
155,300 |
4:00 PM ET on Jul 2, 2009
Quote delayed at least 20 minutes.
|
|
Recent Releases
Jun 4, 2009
Pain Therapeutics Invited to Present At Two Investor Conferences
May 5, 2009
Pain Therapeutics Initiates Clinical Study in Cancer Patients
View all releases »
|
